Search Results - "Prostate--Cancer"

Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticity.

Authors: Eyunni, Sanjana Mannan, Rahul Zhang, Yuping et al.

Source: Science. 9/4/2025, Vol. 389 Issue 6764, p1-18. 18p.

EGFL7 Inhibits the Immune Response in Metastatic Castration-Resistant Prostate Cancer by Deactivating Endothelial Intercellular Adhesion Molecule-1.

Authors: Lee, Seung Soo Lee, Ji Young Lee, Hyun Jung et al.

Source: World Journal of Men's Health. Jul2026, Vol. 44 Issue 3, p702-712. 11p.

Predictieve waarde van SUVmax bij primair gemetastaseerd hormoonsensitief prostaatcarcinoom.

Alternate Title: Predictive value of the SUVmax in de novo hormone-sensitive prostate cancer.

Authors: Siem, Gabriel Ettema, Rosemarijn H. Lavalaye, Jules et al.

Source: Tijdschrift voor Urologie. Jul2026, Vol. 16 Issue 4, p90-96. 7p.

Cholesterol‐Mediated Metabolic‐mechanotransductive Crosstalk Orchestrates Castration Resistance in Prostate Cancer.

Authors: Liu, Shaojie Xu, Chao Jiang, Jun et al.

Source: Advanced Science. Jun2026, p1. 19p. 8 Illustrations.

Incidence and Short- to Intermediate-Term Oncological Outcomes of Pathological T0 Prostate Cancer After Robot-Assisted Radical Prostatectomy: A Multicenter, Retrospective Cohort Study in Japan (MSUG94 Group).

Authors: Tomioka-Inagawa, Risa Tomioka, Masayuki Tatenuma, Tomoyuki et al.

Source: Current Oncology. Jun2026, Vol. 33 Issue 6, p303. 10p.

GMP-compliant automated synthesis and quality control of [¹⁷⁷Lu]Lu-PSMA-I&T using the GAIA/LUNA Elysia-Raytest module for the treatment of metastatic castration-resistant prostate cancer.

Authors: Coussirou, Amélie Six, Mélodie Edet-Sanson, Agathe et al.

Source: EJNMMI Radiopharmacy & Chemistry. 5/19/2026, Vol. 11 Issue 1, p1-17. 17p.

Eli Lilly-Backed Novel Cancer Therapy Firm Raises $315 Million.

Authors: Tong, Amber (AUTHOR)

Source: Bloomberg.com. 7/15/2026, pN.PAG-N.PAG. 1p.

Quantitative bone SPECT/CT-derived tumor burden as a prognostic biomarker in metastatic castration-resistant prostate cancer treated with Ra-223.

Authors: Fukushima, Yoshimitsu Kimura, Go Akatsuka, Jun et al.

Source: EJNMMI Reports. 7/13/2026, Vol. 10 Issue 1, p1-20. 20p.

Joint modelling of PSA dynamics and prostate cancer risks: A population-based study in men without prior prostate cancer.

Authors: Akynkozhayev, Birzhan Christoffersen, Benjamin Lantz, Anna et al.

Source: PLoS ONE. 7/10/2026, Vol. 21 Issue 7, p1-12. 12p.

Sustainable gold nanoparticles using Jania rubens, targeted therapeutic potential in prostate cancer and mechanistic insights via GO/KEGG pathway analysis.

Authors: El-Naggar, Noura El-Ahmady Sarhan, Eman M. Amien, Banan Saher et al.

Source: Scientific Reports. 7/11/2026, Vol. 16 Issue 1, p1-36. 36p.

Identification of the oxidation stress-related gene signatures and functional verification of MINK1 in prostate cancer cells.

Authors: Liang, Shuai Zhou, Shuhua Tang, Yangshuo et al.

Source: PLoS ONE. 7/8/2026, Vol. 21 Issue 7, p1-21. 21p.

¹⁸F‐PSMA‐1007 PET/CT Demonstrates Higher Accuracy for Biochemically Recurrent Prostate Cancer Compared to Contemporary Conventional Imaging.

Authors: Stanton, Zachary Woloschuk, Bonnie Tamm, Alexander et al.

Source: Advances in Urology. 7/5/2026, Vol. 2026, p1-8. 8p.

Mistletoe extract (Iscador®) in cancer patients undergoing chemotherapy for prostate and bladder tumors: A prospective observational study.

Authors: Heidari, Somaye-Sadat Ahmadi, Roya Siavashpour, Maryam et al.

Source: Avicenna Journal of Phytomedicine. Jul/Aug2026, Vol. 16 Issue 4, p739-750. 12p.

Evidence for the Additional Health Benefits Associated with Phosphodiesterase 5 Inhibitors when Used for Treating Erectile Dysfunction, with a Focus on Prostate Cancer Patients and Other Associated Conditions.

Authors: Naranjo, Alexandra Hackett, Geoffrey Ian Smith, Sophie et al.

Source: World Journal of Men's Health. Jul2026, Vol. 44 Issue 3, p582-592. 11p.

Relationship between Prostate Cancer and Benign Hyperplasia: Role of Inflammation-Induced Oxidative Stress, Vitamin C, and Epigenetics.

Authors: Zarakowska, Ewelina Guz, Jolanta Gackowski, Daniel et al.

Source: World Journal of Men's Health. Jul2026, Vol. 44 Issue 3, p572-581. 10p.

Prostate Cancer at the Microbial Crossroads: Illuminating a New Frontier in Precision Medicine.

Authors: Kwon, Whi-An Kim, Heeyeon Song, Yong Sang

Source: World Journal of Men's Health. Jul2026, Vol. 44 Issue 3, p508-532. 25p.

Reproducibility of natural-language-driven statistical workflows compared with conventional software for diagnostic metrics in prostate cancer research.

Authors: Emanuel Lagos-Beitz, Horst Trujillo-Martínez, Guillermo Antonio González-Quirós, Carlos et al.

Source: Investigative & Clinical Urology. Jul2026, Vol. 67 Issue 4, p340-348. 9p.

An artificial intelligence model integrating clinico-laboratory data and single nucleotide polymorphism-based genomic risk for prostate cancer diagnosis in Korean men.

Authors: Jung, Jae Hung Han, Gong Ho So, Beomgi et al.

Source: Investigative & Clinical Urology. Jul2026, Vol. 67 Issue 4, p331-339. 9p.

The evolving landscape of robot-assisted radical prostatectomy: A comprehensive review of surgical techniques.

Authors: Jeong, Seung-hwan Kwak, Cheol

Source: Investigative & Clinical Urology. Jul2026, Vol. 67 Issue 4, p311-317. 7p.

Tumor-associated M2 macrophages promote prostate cancer invasion through the M-CSF-PCLAF pathway.

Authors: Ou, Yitian Ye, Chunwei Jiang, Haiyang et al.

Source: PLoS ONE. 6/22/2026, Vol. 21 Issue 6, p1-21. 21p.